EDWARDS LIFESCIENCES CORP (NY:EW)
86.65
0.4 (0.46%)
| EDWARDS LIFESCIENCES CORP (NY:EW) Delayed : |
| Previous Close |
$87.05 |
|
52 Week High |
$94.55 |
|
| Open |
$88.00 |
|
52 Week Low |
$52.86 |
| Day High |
$88.25 |
|
P/E |
23.17 |
| Day Low |
$85.61 |
|
EPS |
$3.74 |
| Volume |
725,056 |
|
|
|
| More EW Info:
Chart
SEC Filings
Profile
Historical
Options
|
Edward Lifesciences Summary
Edwards Lifesciences Corporation provides various products and
technologies designed to treat cardiovascular diseases. It focuses
primarily on heart valve disease, peripheral vascular disease, and
critical care technologies. The company offers tissue heart valves and
repair products, which are used to replace or repair a patient's
diseased or defective heart valve; and provides hemodynamic monitoring
systems that are used to measure a patient's heart function in surgical
and intensive care ...more
Executives
Michael Mussallem - Chairman, CEO
Links
http://www.edwards.com/
-
Feb 5, 2010 10:17 AM
Craig-Hallum Downgrades Edward Lifesciences (EW) to Accumulate
-
Feb 4, 2010 04:11 PM
Edwards Lifesciences (EW) Misses Q4 EPS by 1c; Guides In-Line
-
Feb 3, 2010 03:58 PM
Trading Radar for 02/04: Bunge (BG), Spectra Energy (SE), MasterCard (MA), Con-Way (CNW), Hospira (HSP) Report
-
Jan 8, 2010 11:34 AM
Rodman & Renshaw Starts NXTM, THOR, MEND, SPNC at Outperform, EW, SRDX at Underperform
-
Jan 8, 2010 07:05 AM
Goldman Sachs Added Edwards Lifesciences (EW) to its Conviction Buy List
View All Reports
StreetInsider Reports on EW by Category
-
Jan 19, 2010 01:58 PM
Have We Reached the Top of the Stock Market?
-
Jan 19, 2010 03:38 AM
Insider Buying Drops to Lowest Levels in a Year
-
Jan 8, 2010 11:40 AM
Analyst Upgrades, Downgrades and Initiations: ADS, ANF, BCS, EXC, HRS, KO, TJX, WEN ...
-
Dec 11, 2009 10:20 AM
Analyst upgrades, downgrades and initiations: YHOO, EW, BWY, BRO, BNI, FFIV, AOL, CYPB, ATML ...
-
Oct 23, 2009 04:02 AM
21 Breakout Stocks to Watch, And How to Generate Income with Apple LEAP Options
View All Blogs
Comments on EW
No comments are currently available.